Research Shows How To Avoid Misleading With Statistics

Published Sep 17, 2012
Ann Arbor, MI, USA – Research conducted by the University of Michigan School of Public Health shows that when researchers compare two or more treatments, the choice of how to express results may affect their conclusion about which is best. Using a mathematical model and a sophisticated software program, Edward Norton, PhD, and his team demonstrated that the choice between risk ratio, odds ratio and risk difference could result in different outcomes through what is called rank reversal. Previous research has suggested that rankings through indirect comparisons can be assumed to be consistent across the various methods. Norton said, “The outcome of the team’s research impacts best practices for making indirect comparisons.” He continued on to say, “With the government funding more research that uses these different methods, researchers need to be aware that the method they choose could influence the conclusion." The paper, “Rank Reversal in Indirect Comparisons,” is published in Value in Health.

Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research as well as policy papers to help health care leaders make evidence-based decisions. The journal is published bi-monthly and has over 8,000 subscribers (clinicians, decision makers, and researchers worldwide).

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health. For more information: www.ispor.org

Related Stories

Global Expert Panel Releases Good Practices Guidance for Developing or Updating Health Technology Assessment Guidelines

Jan 14, 2025

ISPOR announced today the publication of a tripartite task force report outlining good practices for developing or updating health technology assessment (HTA) guidelines.

Rethinking Value Assessment for Orphan Drugs

Dec 18, 2024

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the publication of a special themed section of research papers that document challenges in rare disease evidence and economic evaluation and policy as well as ways in which the environment is evolving to address them.

ISPOR Releases Emerging Good Practices Guidance on Quantifying Specialized Knowledge in Healthcare

Nov 6, 2024

ISPOR announced the publication of an ISPOR Good Practices Report that identifies existing structured expert elicitation protocols that can support healthcare decision making and provides important insights on how to choose which protocols may be the most appropriate for different scenarios, such as time-constrained decisions, early-stage technology assessments, and public health policies.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×